OM5A Stock Overview
Engages in developing and commercializing medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Observe Medical ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 0.03 |
| 52 Week High | NOK 0.047 |
| 52 Week Low | NOK 0.0021 |
| Beta | 0.38 |
| 1 Month Change | 15.27% |
| 3 Month Change | 0% |
| 1 Year Change | 100.00% |
| 3 Year Change | -98.26% |
| 5 Year Change | -97.55% |
| Change since IPO | -95.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| OM5A | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -5.0% | -3.3% | -2.0% |
| 1Y | 100.0% | -8.5% | 6.9% |
Return vs Industry: OM5A exceeded the German Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: OM5A exceeded the German Market which returned 6.9% over the past year.
Price Volatility
| OM5A volatility | |
|---|---|
| OM5A Average Weekly Movement | 11.8% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: OM5A's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: OM5A's weekly volatility has decreased from 103% to 12% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 9 | Jorgen Mann | observemedical.com |
Observe Medical ASA engages in developing and commercializing medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries. It offers Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control; and Biim, a wireless pocketable ultrasound device for display of the ultrasound image and video for nurses and medical staff. The company also offers Unometer, Safeti Plus, Unometer 500, UnoMeter, and AbdoPressure products used for drainage, collection, and measurement of urine output from patients, as well as provides medtech devices and disposables within urine measurement, anesthesiology/ICUs, and wound care products.
Observe Medical ASA Fundamentals Summary
| OM5A fundamental statistics | |
|---|---|
| Market cap | €8.29m |
| Earnings (TTM) | -€4.03m |
| Revenue (TTM) | €2.47m |
3.4x
P/S Ratio-2.1x
P/E RatioIs OM5A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OM5A income statement (TTM) | |
|---|---|
| Revenue | NOK 29.18m |
| Cost of Revenue | NOK 19.18m |
| Gross Profit | NOK 10.00m |
| Other Expenses | NOK 57.68m |
| Earnings | -NOK 47.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 18, 2025
| Earnings per share (EPS) | -0.19 |
| Gross Margin | 34.26% |
| Net Profit Margin | -163.41% |
| Debt/Equity Ratio | 52.1% |
How did OM5A perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 19:26 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Observe Medical ASA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|